Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Flow (Pulsatile and Non-Pulsatile), Design (Implantable Ventricular Assist Devices and Transcutaneous Ventricular Assist Devices), and Application (Bri
Impantable Ventricular Assist Devices Segment to Grow Significantly During 2022-2028For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
According to our new study on ""Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type of Flow, Design, and Application," the market is expected to reach US$ 1,806.19 million by 2028 from US$ 1,272.08 million in 2021. It is estimated to grow at a CAGR of 5.1% from 2022 to 2028. A significantly increasing prevalence of target diseases and rising geriatric population across the world drive the market growth. However, growing product recalls and complications associated with left ventricular assist devices hamper the market growth.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
COVID-19 Pandemic Impact on left ventricular assist device market
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
In 2020, the implementation of stringent lockdown regulations across several countries due to the effects of the COVID-19 pandemic disrupted the production and procedures of left ventricular assist devices. Also, many countries and cities were shut down amid the lockdown, causing the cancellation of treatments and doctor appointments. Patients suffering from critical issues need physical attention in the clinics. Cardiac issues are one of the most preventable public health challenges in all regions. Due to the rising intensity of the COVID-19 pandemic, the patients could not visit the clinics. Moreover, there was shortage of staff. Hence, the COVID-19 pandemic negatively impacted the global left ventricular assist device market.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
During the COVID-19 outbreak, healthcare systems were overburdened, and the delivery of medical care to all patients became a challenge across the world. In addition, the medical device industry was facing the negative impact of COVID-19 pandemic. As the pandemic unfolded, medical device companies found difficulties managing their operations. This disrupted and restricted the companies' ability to distribute products and resulted in the temporary closures of their facilities. However, hospitals gradually resumed elective procedures as the COVID-19 recovery rate increased. Hence, the demand for medical equipment, including left ventricular assist device, is expected to increase in the coming years.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
Emerging countries such as India, China, Argentina, Brazil, the UAE, and South Africa are expected to offer significant growth opportunities for LVAD market players mainly due to their rising patient population, increasing R&D activities, growing CVD awareness, rising disposable incomes, improving healthcare infrastructure, and comparatively lenient policies compared to developed countries. Also, emerging markets have seen a sustained increase in heart failure cases over the past decade, driven by the growing target population of patients, rising cardiovascular disease,, and increasing medical tourism. According to the World Economic Forum, Brazil, Russia, India, China, and South Africa were among the fastest-growing economies globally as of 2017 and are expected to account for a third of total global health spending by 2022. Further, increasing competition in well-established markets will force LVAD manufacturers to focus on emerging markets in the coming years, which is expected to create lucrative opportunities for the market players in the coming years.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
ABIOMED Inc, Abbott Laboratories, Medtronic Plc, LivaNova Plc, Jarvik Heart Inc, Terumo Corp, Berlin Heart GmbH, BiVACOR Inc, Evaheart Inc, and BioVentrix Inc are among the left ventricular assist device market players.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
Left Ventricular Assist Device Market, by Region, 2021 (%)
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
Source: The Insight Partners Analysis
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
The report segments the left ventricular assist device market as follows:
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
The left ventricular assist device market is segmented on the basis of type of flow, design, application, and geography. Based on type of flow, the market is segmented into non-pulsatile and pulsatile. Based on design, the market is bifurcated into transcutaneous ventricular assist devices and implantable ventricular assist devices. By application, the left ventricular assist device market is segmented into destination therapy, bridge-to-transplantation, bridge-to-candidacy, and bridge-to-recovery. Based on geography, the global left ventricular assist device market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of South and Central America).
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2354/left-ventricular-assist-device-market
Thinking Caps Market Reports
Bangalore, India
Sayantan Paul
CEO and Founder
+1 800 257 6445
connect@thinkingcapsrc.com
Thinking Caps is a research powerhouse dedicated towards making your business decisions easier, faster and cost effective.
Equipped with a multi-publisher dynamic repository of readily available syndicate industry reports, Thinking Caps helps you maximize RoI through incisive insights, credible data analysis, updated company information, and the opportunity to expand your horizon through additional bespoke research. We help you take tangible decisions positively impacting your business growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Flow (Pulsatile and Non-Pulsatile), Design (Implantable Ventricular Assist Devices and Transcutaneous Ventricular Assist Devices), and Application (Bri here
News-ID: 2967905 • Views: …
More Releases from Thinking Caps Market Reports
ISDN Modem Market Forecast to 2024 - COVID-19 Impact and Global Analysis By Type …
According to the new research report published by The Insight Partners on ""ISDN Modem Market Forecast to 2024 - COVID-19 Impact and Global Analysis,"" the market is expected to register a CAGR of -80.9% from 2022 to 2024 to reach US$ 36.89 thousand by 2024.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2352/isdn-modem-market
Epygi Technologies LLC, Polycom, Ekinops, Xiamen Yeastar Information Technology Co. Ltd., and HypermediaS are among the leading ISDN…
Europe Medical Can-nabis Market Forecast to 2028 - COVID-19 Impact and Regional …
Rising Research Activities on Medicinal Use of Can-nabis to Drive Europe Medical Can-nabis Market
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2353/europe-medical-can-nabis-market
According to a new research study titled ""Europe Medical Can-nabis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Medical Application, and Compound,"" the market is expected to grow from US$ 492.1 million in 2021 to US$ 13,801.0 million by 2028. It is…
Edge Banding Materials Market Forecast to 2028 - COVID-19 Impact and Global Anal …
The scope of our recent study on the "Edge Banding Materials Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Material [Plastic (PVC, ABS, Acrylic, and Others), Wood, Metal, and Others] and End Use (Residential and Commercial & Industrial)" includes the factors fueling the market growth, revenue estimation and forecast, and market share analysis, along with the identification of significant market players and their key developments.
For sample…
Mobile Water Treatment Market Forecast to 2028 - COVID-19 Impact and Global Anal …
According to our latest market study, "Mobile Water Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Offering, Application, and End User," the market is expected to grow from US$ 2,448.31 million in 2022 to US$ 4,453.12 million by 2028; it is expected to grow at a CAGR of 10.5% from 2022 to 2028.
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2356/mobile-water-treatment-market
Truck-Mounted Mobile Water Treatment Plants…
More Releases for Ventricular
Ventricular Assist Device Market Report Up tp 2031
Visiongain has published a new report on Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
GlobalVentricular Assist Device market was valued at US$ xx billion in 2020 and is projected to reach at a market value of…
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction
Overview
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018
Top Companies mentioned
Bayer AG
Innopharmax Inc
Mesoblast Ltd
Novartis AG
Quantum Genomics SA
TiGenix NV
Left Ventricular Dysfunction Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -…
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape.
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease.
Report Highlights
Publisher's Pharmaceutical and Healthcare…
Global Ventricular Fibrillation Market 2021- Analysis and Trends
“Global Ventricular Fibrillation Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
Ventricular fibrillation is a heart rhythm problem that occurs when the heart beats with rapid, erratic electrical impulses. This causes pumping chambers in your heart (the ventricles) to quiver uselessly, instead of pumping blood. Together, all four chambers pump blood to and from the body. When the atria, the two upper chambers, contract at an excessively high…
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major…
Ventricular Assist Device Market: Global Markets & Advanced Technologies
North America Ventricular Assist Device Market: Overview
Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts…